Kinetic properties of 99mTc-Q12 in canine myocardium. | Zendy

Myron C. Gerson | Zendy; R. W. Millard | Zendy; Nancy J. Roszell | Zendy; Anthony J. McGoron | Zendy; Marjorie Gabel | Zendy; Lee C. Washburn | Zendy; Danuta Biniakiewicz | Zendy; D’Arbra Blankenship | Zendy; W. Mallin | Zendy; R. C. Elder | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Kinetic properties of 99mTc-Q12 in canine myocardium.

Author(s) -

Myron C. Gerson,

R. W. Millard,

Nancy J. Roszell,

Anthony J. McGoron,

Marjorie Gabel,

Lee C. Washburn,

Danuta Biniakiewicz,

D’Arbra Blankenship,

W. Mallin,

R. C. Elder

Publication year - 1994

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.89.3.1291

Subject(s) - medicine , blood flow , dipyridamole , coronary vasodilator , perfusion , circumflex , cardiology , hemodynamics , artery , coronary circulation , vasodilation , coronary occlusion , ischemia , anesthesia

99mTc-Q12 is a new Tc(III) perfusion imaging agent that permits prompt myocardial visualization in humans. We postulated that 99mTc-Q12 myocardial activity is related to actual myocardial blood flow during conditions of myocardial ischemia and pharmacological coronary artery vasodilation and that 99mTc-Q12 shows little or no myocardial redistribution as long as 4 hours after intravenous injection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research